Insurance Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.

Press releases published on April 14, 2026

Voice AI Goes Mainstream in Insurance as Consumers Prioritize Speed and Accuracy, Sonant Survey Shows
AOG Acquires ITH Life LLC, Expanding Digital and InsurTech Capabilities
FORMER FDA COMMISSIONER DR. STEPHEN HAHN JOINS LAMASSU BIOTECH BOARD OF DIRECTORS
Olympus Insurance Company Enters the Catastrophe Bond Market With $120 Million Abacab Re Debut Transaction
Five Sigma Upgrades Its Claims Analytics With Native Embedded Reporting, Eliminating the Need for External BI Tools
Xceedance Appoints Swapna Allapur as Global Chief People Officer to Support Next Phase of Enterprise Growth
FDIC Mid-Rise and High-Rise Symposium:  The Built Environment is Changing Fast, and the Fire Attack Must Change with It
EnforceAuth Launches Free AI Security Platform With 1M Monthly Decisions
Enhancing Asset Manager Distribution Intelligence with AI
Relevantz Strengthens Ottawa Presence with Move into Kanata
Couplr.ai Partners with InterGen Data to Drive Organic Growth, Advisor Productivity, Client Retention, and Revenue
GoldHaven Announces Change of Auditor
POET Technologies Provides Clarity on its Passive Foreign Investment Company (PFIC) Status
CHSN Investor News: If You Have Suffered Losses in Chanson International Holding (NASDAQ: CHSN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
기업의 약 80%는 “데이터 접근성 문제로 AI 활용에 제약”… Cloudera 보고서
Cloudera 最新报告发现:近 80% 的企业表示 AI 发展受限于数据访问难题
クラウデラの最新レポートによると、企業の80%近くが、AIの導入がデータアクセスの課題によって阻害されていると回答
Hampir 80% Perusahaan Menyatakan AI Terhalang oleh Cabaran Akses Data, Laporan Baharu Cloudera Mendedahkan
Cloudera 最新報告發現,近 80% 企業認為數據存取的困難阻礙了人工智能的發展
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

Share this page:

Sign up for:

Insurance Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.